In vivo measurement of [C-11]verapamil kinetics in human tissues

Objective: To evaluate [C-11]verapamil kinetics in humans. Methods: After intravenous injection of [C-11]verapamil (370 MBq, specific activity >1600 GBq/mmol), kinetics were evaluated in five cancer patients u sing positron emission tomography (PET). Results: One hour after injection, accumulation of [C-11] in lungs, heart a nd tumour was 43.0%, 1.3% and 0.9% of the injected verapamil dose, respecti vely. Half-lives of [C-11]verapamil in these tissues were 46.2 min, 73.8 mi n and 23.7 min, respectively. Conclusions: Intravenously administered [C-11] was mainly extracted by the lungs. Transport of a [C-11]ve-rapamil bolus out of solid tumour tissue is relatively fast.